ISSAQUAH, Wash.--(BUSINESS WIRE)--Spacelabs Healthcare, which pioneered medical telemetry decades ago by monitoring the vital signs of orbiting astronauts, is again making history with the launch of AriaTele, a new generation of feature-rich telemetry transmitters. Unlike traditional telemetry transmitters, the lightweight AriaTele offers a unique color screen to display heart rate/ rhythm, pulse rate and oxygen saturation level, providing immediate feedback to the caregiver on ECG & SpO2 signal quality.
“Spacelabs invented medical telemetry, was first to introduce telemetry to hospitals and first to offer telemetry for the WMTS,” said Nicholas Ong, President of Spacelabs Healthcare. “AriaTele has been built upon this expertise to continue our rich history of innovation.”
Today’s hospitals depend on telemetry for the continuous, remote monitoring of ambulatory patients’ physiological parameters. AriaTele’s display now offers caregivers the added confidence of knowing that they have the data they need while at the patient’s side, plus the convenience and time savings of not having to check with the central station.
AriaTele is the latest addition to Spacelabs’ Art of Monitoring portfolio that includes the qubeTM and XPREZZONTM patient monitors, and ICS XPREZZTM mobile app for iPad.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Company’s products. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.